Myasthenia gravis experts and patient representatives from the five Nordic countries formed a working group to prepare treatment guidance based on a systematic literature search and consensus meetings. Successful treatment rests on a timely combination of symptomatic and immunosuppressive interventions. Due to spontaneous disease fluctuations, comorbidities, and changes in life conditions, regular long‐term specialized follow‐up is needed.
All Keywords
【저자키워드】 Treatment, Immunosuppression, myasthenia gravis, thymus, acetylcholine receptor antibodies,
【저자키워드】 Treatment, Immunosuppression, myasthenia gravis, thymus, acetylcholine receptor antibodies,